Skip to main content
Fig. 6 | Journal of Experimental & Clinical Cancer Research

Fig. 6

From: The role of dosimetry and biological effects in metastatic castration–resistant prostate cancer (mCRPC) patients treated with 223Ra: first in human study

Fig. 6

Number of DC (a) and MN (b) observed in the PBLs (non-target-tissue) plotted against the AD to blood. Solid line represents the fitted curve and the grey area the 95% confidence interval. Bland-Altman plots of difference in number of c) DC and d) MN and the AD to blood. Red line represents the average between the two methods and blue dotted line indicate the 95% limits of agreement for comparison

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us